TP induces the oncogene Pi3 Kinase/Akt which is coupled to the activation of large-conductance potassium calcium channels and Transient Receptor Potential Vanilloid 1 (TRPV1) known to be emerging pharmacological targets in cancer (12, 44–46). The gene discussed is AKT1; the disease is cancer.